Portal de investigación
Concordance of baseline RAS mutational status (ms) between tissue and cell-free DNA (cfDNA) and association with overall response rate (ORR) in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study (cohort 2) (NCT02792478)
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Valladares-Ayerbes, M
- Safont, MJ
- Gonzalez-Flores, E
- Garcia-Alfonso, P
- Aguilar, EA
- Munoz, AML
- Nogueras, LC
- Ferrer, EF
- Salas, NR
- Llanos, M
- Trujillo, OAC
- Caceres, PP
- Cruz-Hernandez, JJ
- Fernandez, MS
- Salvia, AS
- Garcia-Carbonero, R
- Sureda, BM
- Conesa, MAV
- Vila, AL
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 0923-7534, 1569-8041
- Tipo:
- Meeting Abstract
- Páginas:
- 560-560
- Factor de Impacto:
- 8,590 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
ANNALS OF ONCOLOGY ELSEVIER
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Valladares,M,Safont,MJ,Gonzalez,E,Garcia,P,Aguilar,EA,Munoz,A,Nogueras,LC et al. Concordance of baseline RAS mutational status (ms) between tissue and cell-free DNA (cfDNA) and association with overall response rate (ORR) in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study (cohort 2) (NCT02792478). Congress of the European-Society-for-Medical-Oncology (ESMO). 2021. ELECTR NETWORK-SEP 16-21. RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS:ELSEVIER. 2021 p.p. 560-560.